| Mr Christopher Roy Boulanger, LPN | |
|
33 Sanford Ln, Bethlehem, CT 06751-1816 | |
| (203) 980-1421 | |
| Not Available |
| Full Name | Mr Christopher Roy Boulanger |
|---|---|
| Gender | Male |
| Speciality | Licensed Practical Nurse |
| Location | 33 Sanford Ln, Bethlehem, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578705422 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | 293066-1 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Christopher Roy Boulanger, LPN 33 Sanford Ln, Bethlehem, CT 06751-1816 Ph: (203) 980-1421 | Mr Christopher Roy Boulanger, LPN 33 Sanford Ln, Bethlehem, CT 06751-1816 Ph: (203) 980-1421 |
News Archive
W. L. Gore & Associates today announced the introduction of the GORE® 3D Imaging System, a new internet cloud-based 3D advanced visualization and decision support system that will change the paradigm of pre-case planning. The revolutionary new system, which is on exhibit at the VEITHsymposium (37th Annual Symposium on Vascular and Endovascular Issues), reflects Gore's ongoing commitment to supporting physicians in making informed treatment decisions.
Cancer Research UK scientists have tamed a virus so that it attacks and destroys cancer cells but does not harm healthy cells, according to a paper published in PLoS Pathogens, today.
Until recently, many elderly patients with stage I non-small cell lung cancer were left untreated because treatment may not improve their quality of life. However, stereotactic ablative radiotherapy (SABR) has become one of the standards of treatment for these patients. The outpatient treatment given over a two-week period allows frail patients to undergo the treatment.
Shimmer Research, a global leader in wearable technology for research applications, today announced that a team of researchers from Letterkenny Institute of Technology and Letterkenny University Hospital (LUH) will be using Shimmer's Verisense continuous monitoring platform to study fatigue accurately in individuals with breast cancer.
Patients who choose to spend their last days at home with specialized care and monitoring can safely be given opioids to control pain and other symptoms without reducing survival time, according to a study published in Journal of Palliative Medicine (JPM), a peer-reviewed journal from Mary Ann Liebert, Inc.
› Verified 6 days ago